# ATAZANAVIR SULFATE
> **ANDA091673** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2014-04-22
## Drug
- **FDA Application Number:** ANDA091673
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ATAZANAVIR SULFATE
- **Generic name:** ATAZANAVIR SULFATE
- **Active ingredients:** ATAZANAVIR SULFATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2014-04-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091673)
---
*AI Analytics · CC0 1.0*